Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests mitochondria infusion into brain vessels during blood flow restoration

Tests healthy mitochondria infused into brain vessels in adults with reduced brain blood flow.

Plain-language title generated from the registry record
Registry title: Autologous Mitochondrial Transplant for Cerebral Ischemia

Key facts

Where
Seattle, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT04998357, who can take part

Where in United States

  • Harborview Medical CenterSeattle, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Washington
Trial code
NCT04998357
Record updated
21 May 2025
Original description
The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.Read full original descriptionShow less

Study Title: Autologous Mitochondrial Transplant for Cerebral Ischemia

The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.

Inclusion: Eligible for endovascular thrombectomy to treat acute large vessel occlusion; Eligible for angioplasty (microcatheter-based balloon/mechanical and chemical angioplasty) to treat acute cerebral vasospasm after aneurysmal subarachnoid hemorrhage; Subjects for whom there is likely to be enough time to obtain meaningful consent from patient or legally-authorized representative.

Exclusion: Known mitochondrial disease; Unable to receive a brain MRI scan; Hemodynamically unstable patients in whom standard of care endovascular reperfusion treatment cannot safely be performed or completed.

ClinicalTrials.gov NCT04998357